These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 29904968

  • 1. Safety and efficacy of topical cantharidin for the treatment of pediatric molluscum contagiosum: a prospective, randomized, double-blind, placebo-controlled pilot trial.
    Guzman AK, Schairer DO, Garelik JL, Cohen SR.
    Int J Dermatol; 2018 Aug; 57(8):1001-1006. PubMed ID: 29904968
    [Abstract] [Full Text] [Related]

  • 2. Safety and Efficacy of VP-102, a Proprietary, Drug-Device Combination Product Containing Cantharidin, 0.7% (w/v), in Children and Adults With Molluscum Contagiosum: Two Phase 3 Randomized Clinical Trials.
    Eichenfield LF, McFalda W, Brabec B, Siegfried E, Kwong P, McBride M, Rieger J, Willson C, Davidson M, Burnett P.
    JAMA Dermatol; 2020 Dec 01; 156(12):1315-1323. PubMed ID: 32965495
    [Abstract] [Full Text] [Related]

  • 3. A Phase 2 Open-Label Study to Evaluate VP-102 for the Treatment of Molluscum Contagiosum.
    Niazi S, Brabec B, Anschutz L, Willson C, Davidson M, Burnett P.
    J Drugs Dermatol; 2021 Jan 01; 20(1):70-75. PubMed ID: 33400412
    [Abstract] [Full Text] [Related]

  • 4. Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial.
    Coloe Dosal J, Stewart PW, Lin JA, Williams CS, Morrell DS.
    Pediatr Dermatol; 2014 Jan 01; 31(4):440-9. PubMed ID: 22897595
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and Safety of Topical Cantharidin Treatment for Molluscum Contagiosum and Warts: A Systematic Review.
    Vakharia PP, Chopra R, Silverberg NB, Silverberg JI.
    Am J Clin Dermatol; 2018 Dec 01; 19(6):791-803. PubMed ID: 30097988
    [Abstract] [Full Text] [Related]

  • 6. Pooled Results of Two Randomized Phase III Trials Evaluating VP-102, a Drug-Device Combination Product Containing Cantharidin 0.7% (w/v) for the Treatment of Molluscum Contagiosum.
    Eichenfield LF, Siegfried E, Kwong P, McBride M, Rieger J, Glover D, Willson C, Davidson M, Burnett P, Olivadoti M.
    Am J Clin Dermatol; 2021 Mar 01; 22(2):257-265. PubMed ID: 33599960
    [Abstract] [Full Text] [Related]

  • 7. Childhood molluscum contagiosum: experience with cantharidin therapy in 300 patients.
    Silverberg NB, Sidbury R, Mancini AJ.
    J Am Acad Dermatol; 2000 Sep 01; 43(3):503-7. PubMed ID: 10954663
    [Abstract] [Full Text] [Related]

  • 8. Cantharidin therapy for molluscum contagiosum in children.
    Epstein E.
    J Am Acad Dermatol; 2001 Oct 01; 45(4):638. PubMed ID: 11568766
    [No Abstract] [Full Text] [Related]

  • 9. Cantharidin use among pediatric dermatologists in the treatment of molluscum contagiosum.
    Coloe J, Morrell DS.
    Pediatr Dermatol; 2009 Oct 01; 26(4):405-8. PubMed ID: 19689514
    [Abstract] [Full Text] [Related]

  • 10. Combination topical treatment of molluscum contagiosum with cantharidin and imiquimod 5% in children: a case series of 16 patients.
    Ross GL, Orchard DC.
    Australas J Dermatol; 2004 May 01; 45(2):100-2. PubMed ID: 15068455
    [Abstract] [Full Text] [Related]

  • 11. Parental satisfaction, efficacy, and adverse events in 54 patients treated with cantharidin for molluscum contagiosum infection.
    Cathcart S, Coloe J, Morrell DS.
    Clin Pediatr (Phila); 2009 Mar 01; 48(2):161-5. PubMed ID: 18936288
    [Abstract] [Full Text] [Related]

  • 12. Beetle juice: a guide for the use of cantharidin in the treatment of molluscum contagiosum.
    Moye V, Cathcart S, Burkhart CN, Morrell DS.
    Dermatol Ther; 2013 Mar 01; 26(6):445-51. PubMed ID: 24552407
    [Abstract] [Full Text] [Related]

  • 13. Cantharidin: a comprehensive review of the clinical literature.
    Torbeck R, Pan M, DeMoll E, Levitt J.
    Dermatol Online J; 2014 Jun 15; 20(6):. PubMed ID: 24945640
    [Abstract] [Full Text] [Related]

  • 14. YCANTHTM (Cantharidin) Topical Solution.
    Gupta AK, Mann A, Vincent K, Abramovits W.
    Skinmed; 2023 Jun 15; 21(5):360-363. PubMed ID: 37945366
    [Abstract] [Full Text] [Related]

  • 15. Cantharidin Topical Solution 0.7%: First Approval.
    Keam SJ.
    Paediatr Drugs; 2024 Jan 15; 26(1):95-100. PubMed ID: 38007409
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of topical application of 15% and 10% potassium hydroxide for the treatment of Molluscum contagiosum.
    Teixidó C, Díez O, Marsal JR, Giner-Soriano M, Pera H, Martinez M, Galindo-Ortego G, Schoenenberger JA, Real J, Cruz I, Morros R.
    Pediatr Dermatol; 2018 May 15; 35(3):336-342. PubMed ID: 29479727
    [Abstract] [Full Text] [Related]

  • 17. Safety of cantharidin: a retrospective review of cantharidin treatment in 405 children with molluscum contagiosum.
    Moye VA, Cathcart S, Morrell DS.
    Pediatr Dermatol; 2014 May 15; 31(4):450-4. PubMed ID: 24383663
    [Abstract] [Full Text] [Related]

  • 18. A comparative study of topical cantharidin and intralesional PPD to treat molluscum contagiosum.
    Khattab FM, Nasr MM.
    J Dermatolog Treat; 2020 Dec 15; 31(8):850-854. PubMed ID: 31418621
    [Abstract] [Full Text] [Related]

  • 19. Randomized placebo-controlled clinical trial on efficacy and safety of topical 10% Potassium hydroxide for molluscum contagiosum treatment in children.
    Giner-Soriano M, Teixidó C, Marsal JR, Díez O, Pera H, Vlacho B, Morros R, working group for the clinical trial IJG-KOH-2014.
    J Dermatolog Treat; 2019 Dec 15; 30(8):750-756. PubMed ID: 30668179
    [Abstract] [Full Text] [Related]

  • 20. Cantharidin in Dermatology.
    Al-Dawsari NA, Masterpol KS.
    Skinmed; 2016 Dec 15; 14(2):111-4. PubMed ID: 27319954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.